Psilocybin clinical trials at UCSD
3 research studies open to eligible people
COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
open to eligible people ages 18 years and up
Efficacy and Safety of COMP360 Psilocybin therapy in Anorexia Nervosa: a Proof-of-concept Study
San Diego, California and other locations
COMP360 in Participants With TRD
open to eligible people ages 18 years and up
Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)
La Jolla, California and other locations
Psilocybin-assisted Therapy for Phantom Limb Pain
open to eligible people ages 18-75
This double-blind placebo-controlled pilot study seeks to investigate whether psilocybin can be safely administered to people with chronic phantom limb pain (PLP) in a supportive setting with close follow-up, and its effects on pain symptoms and other moods, attitudes, and behaviors. The investigators' primary hypotheses are that psilocybin is safe to administer in people with PLP and that it will reduce scores on measures of pain. The investigators will also assess a number of secondary measures related to the behavioral and neural responses to pain after psilocybin treatment.
San Diego, California
Our lead scientists for Psilocybin research studies include Sidney Zisook, MD Walter Kaye, MD Fadel Zeidan.
Last updated: